Routine laboratory diagnosis of hepatitis C virus infection

Area of Science:

• Virology
• Immunology
• Hepatology

Background:

• Hepatitis C virus (HCV) is a primary cause of non-A, non-B hepatitis transmitted parenterally.
• Genomic analysis of HCV has led to the development of diagnostic assays for detecting antibodies in patient serum.
• First- and second-generation diagnostic tests, utilizing non-structural and both structural/non-structural polypeptides, are currently in use.

Purpose of the Study:

• To compare the diagnostic efficacy of a new synthetic peptide ELISA (HCV-SP ELISA) derived from the structural region of HCV with existing first- and second-generation tests.
• To investigate the potential of detecting HCV-specific structural antigens in semen from patients diagnosed with non-A, non-B (NANB) hepatitis.

Main Methods:

• A comparative study using coded panels to evaluate HCV-SP ELISA against first- and second-generation HCV antibody tests.
• ELISA testing of semen samples from 9 patients with clinically diagnosed NANB hepatitis using antibodies against HCV-specific structural antigens.
• Comparison of results with semen samples from 5 healthy donors.

Main Results:

• Antigens from the structural components of HCV demonstrated superior sensitivity and specificity for early HCV antibody detection compared to non-structural epitopes.
• Epitopes from the structural region of HCV induced a robust antibody response in laboratory animals.
• HCV-specific structural antigens were detected in semen samples from all 9 NANB hepatitis patients.
• Significant levels of HCV-specific antigen were found in the semen of 5 out of 9 NANB hepatitis patients.

Conclusions:

• HCV structural antigens are more effective for sensitive and specific early detection of HCV antibodies.
• The detection of HCV structural antigens in semen suggests a potential new avenue for diagnostic assay development.
• Further rigorous testing is warranted to validate this approach for detecting HCV.